Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07536568

Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia

Efficacy of Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia: A Double-Blind Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the efficacy of sublingual caffeine in reducing recovery time and incidence of postoperative agitation in elderly patients undergoing general anesthesia.

Detailed description

With increasing life expectancy, the proportion of elderly patients undergoing surgical procedures under general anesthesia continues to rise. However, aging is associated with reduced physiological reserve and altered pharmacokinetics and pharmacodynamics of anesthetic agents, making elderly individuals particularly susceptible to delayed emergence from anesthesia. Caffeine, a methyl xanthine compound widely known for its central nervous system (CNS) stimulant properties, has shown potential to accelerate emergence from general anesthesia. It acts as a non-selective antagonist of adenosine A1 and A2A receptors, which play a role in promoting sleep and suppressing arousal. Postoperative agitation and delirium are particularly concerning in older adults due to their association with increased morbidity, functional decline, prolonged hospitalization, and even long-term cognitive impairment.

Conditions

Interventions

TypeNameDescription
DRUGCaffine citratePatients will receive sublingual caffeine at the end of surgery.
OTHERPlaceboPatients will receive sublingual placebo at the end of surgery.

Timeline

Start date
2026-04-15
Primary completion
2026-07-15
Completion
2026-08-30
First posted
2026-04-17
Last updated
2026-04-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07536568. Inclusion in this directory is not an endorsement.